Done. I completed the human immune-oncology panel to 1000 genes, generated all requested deliverables, and ran benchmarking against method panels.

What I used
- Workdir: /home/erwinpi/pantheon-agents/examples/gene_panel_selection/cases/gene_panel_selection_immune/workdir/selection_expert
- Dataset: adata_downsampled_preprocessed.h5ad (120,003 cells × 22,781 genes), author_cell_type_update as label
- Core sub-panel: tables/recommended_subpanel_500.csv (frozen as the backbone)
- Method outputs used: HVG, DE, RandomForest, scGeneFit, SpaPROS (already present in workdir)

What I produced
1) Final 1000-gene panel with annotation
- tables/final_panel_1000_annotated.csv
- tables/final_panel_1000_annotated.xlsx
- tables/final_panel_1000_symbols.txt
- tables/final_panel_README.md
- figures/final_panel_category_counts.png

Curation logic in brief
- Frozen core: the recommended 500-gene separability subpanel.
- Mapped Ensembl → HGNC symbols via AnnData var (ensembl_id index → feature_name). Ensembl IDs normalized by removing version suffixes.
- Completion pool: aggregated consensus ordering from existing method outputs (HVG, DE, RF, scGeneFit, SpaPROS) + consensus_scores.csv; per-method ranks normalized and averaged to avoid dominance by any single method.
- Biological coverage enforced via curated “seed” lists:
  - Major lineages: T/NK, B/plasma, myeloid (mono/macro/DC), granulocytes, epithelial/tumor, endothelial, fibroblast/pericyte
  - Antigen presentation (class I/II machinery)
  - T-cell states and checkpoints (activation/exhaustion/naive/memory/cytotoxicity; co-stimulation)
  - Cytokines/chemokines and receptors (for L–R coverage)
  - Cancer pathways: RTK–RAS–MAPK, PI3K–AKT–mTOR, JAK–STAT, TGFβ, WNT, NOTCH, Hedgehog, NF-κB, Hippo; DNA repair/cell cycle; EMT/hypoxia/metabolism; ECM/CAF; ISG modules
- Redundancy control: ribosomal/mitochondrial/dedicated mitochondrial ribosomal genes capped to ~2% of the panel.
- Annotation: category/subcategory assignment from curated lists; ligand/receptor flags added for key L–R pairs.

2) Benchmarking and comparisons
- ARI vs panel size (100→1000) across methods and the final panel:
  - Figure: figures/ari_vs_size_all_methods.png
  - Tables: tables/ari_vs_size_all_methods.csv and per-method CSVs in tables/ (ari_vs_size_HVG.csv, ari_vs_size_DE.csv, ari_vs_size_SpaPROS.csv, ari_vs_size_RandomForest.csv, ari_vs_size_scGeneFit.csv)
- Five-split benchmarking on the downsampled dataset:
  - Tables: tables/benchmark_metrics_splits.csv
  - Figures (boxplots): figures/benchmark_ARI_boxplot.png, benchmark_NMI_boxplot.png, benchmark_Silhouette_boxplot.png
- UMAP comparisons and quantitative similarity to a reference embedding:
  - Figures: figures/umap_compare_{HVG,DE,SpaPROS,RandomForest,scGeneFit,Final}.png
  - Metrics: tables/umap_similarity_metrics.csv
- UpSet including the final panel vs method panels: figures/upset_with_final_panel.png
- Summary: tables/benchmark_summary.md

Key benchmark highlights (from benchmark_summary.md)
- ARI vs size (curve subset): best ARI per method
  - RandomForest: ARI≈0.393 @200; DE: ≈0.388 @600; Final panel: ≈0.375 @500; scGeneFit: ≈0.367 @1000
- Five-split means
  - Final: ARI=0.365, NMI=0.679, Silhouette=0.137
  - RandomForest: ARI=0.369, NMI=0.678, Silhouette=0.155
  - DE: ARI=0.357, NMI=0.662, Silhouette=0.159
  - scGeneFit: ARI=0.371, NMI=0.663, Silhouette=0.113
- UMAP distance correlation vs reference
  - Final: 0.701 (highest), RF: 0.626, DE: 0.608, scGeneFit: 0.613, SpaPROS/HVG lower on this dataset

Notes on computation
- I used the downsampled preprocessed AnnData for algorithmic benchmarking curves and splits.
- The notebook struggled with some heavy cells; I switched to python_interpreter for the ARI vs size runs, split metrics, UMAP comparisons, and UpSet plotting. This is documented in report_analysis_expert_finalize_and_benchmark.md.

Updated overview
- methods_overview.md: updated with a “Final panel” section and paths to all assets.

Reports
- report_analysis_expert_finalize_and_benchmark.md (full workflow, curation, benchmarking, and biologist interpretation)
- biologist interpretation integrated: balanced TME lineage and program coverage; strong checkpoint/cytotoxicity, antigen presentation, cytokine/chemokine L–R; broad cancer signaling; benchmarking shows robust clustering and manifold preservation with expected limitations on very fine myeloid/DC and T-memory distinctions.

If you want deeper per-gene biological justifications with literature references for the added (non-core) set, I can iterate through the top consensus additions and append referenced rationales.